Physician profile
Pooja Patel
NPI 1821228644
$1,408.45
in general payments reported to CMS, 2019-2025
15 companies · $163 in 2025
The $163 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $495 · 2021: $240 · 2022: $79.12 · 2023: $320 · 2024: $110 · 2025: $163.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $495 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $494.82 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $244.06 | 2021-2023 | Wallflex Duodenal |
| Pfizer INC. | $142.88 | 2019-2024 | |
| Astrazeneca Pharmaceuticals LP | $124.00 | 2021 | |
| Janssen Pharmaceuticals, INC | $119.59 | 2019 | |
| La Jolla Pharmaceutical Company | $110.10 | 2025 | Giapreza |
| Novartis Pharmaceuticals Corporation | $101.98 | 2019 | |
| Janssen Biotech, INC. | $99.00 | 2023 | Stelara |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $93.75 | 2021 | |
| Inari Medical, INC. | $91.33 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Alexion Pharmaceuticals, INC. | $87.37 | 2019 | |
| Emd Serono, INC. | $79.12 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $62.23 | 2019 | |
| Viatris Specialty LLC | $19.90 | 2025 | Yupelri |
| Harmony Biosciences LLC | $18.22 | 2025 | |
| Cala Health, INC. | $14.92 | 2025 | Cala Kiq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pooja Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.